Prevalence of Extended Spectrum Beta Lactamase Producing Bacteria in Two Surgical Wards of a General Hospital

Allocati, N., Masulli, M., Alexeyev, M., F., Di Ilio, C. (2013). Escherichia coli in Europe: an overview. Int. J. Environ. Res. Public Health,10 (12), 6235–6254.10.3390/ijerph10126235388111124287850Search in Google Scholar

Anonymous (2013). Antimicrobial resistance surveillance in Europe Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Available from: European Centre for Disease Prevention and Control on the World Wide Web: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2013.pdf (accessed 11 March 2018).Search in Google Scholar

Anonymous (2017). CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CLSI supplement M100. Wayne, P.A.: Clinical and Laboratory Standards Institute. Available from: http://www.facm.ucl.ac.be/intranet/CLSI/CLSI-2017-M100-S27.pdf (accessed 24 March 2018).Search in Google Scholar

Asir, J., Nair, S., Devi, S., Prashanth, K., Saranathan, R., Kanungo, R. (2015). Simultaneous gut colonisation and infection by ESBL-producing Escherichia coli in hospitalised patients. Australas Med. J., 8 (6), 200–207.10.4066/AMJ.2015.2358449672026213583Search in Google Scholar

Birgand, G., Armand-Lefevre, L., Lolom, I., Ruppe, E., Andremont, A., Lucet, J. C. (2013). Duration of colonization by extended-spectrum beta-lactamase-producing Enterobacteriaceae after hospital discharge. Amer. J. Infect. Control., 41 (5), 443–447.10.1016/j.ajic.2012.05.01522998785Search in Google Scholar

Cantón, R., González-Alba, J. M., Galán, J. C. (2012). CTX-M enzymes: Origin and diffusion. Front. Microbiol.,3, 110.10.3389/fmicb.2012.00110331699322485109Search in Google Scholar

Caratolli, A. (2009). Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother.,53 (6), 2227–2238.10.1128/AAC.01707-08268724919307361Search in Google Scholar

Carlet, J. (2012). The gut is the epicentre of antibiotic resistance. Antimicrob. Resist. Infect. Control., 1, 39.10.1186/2047-2994-1-39355449223181506Search in Google Scholar

Cohen-Nahum, K., Saidel-Odes, L., Riesenberg, K., Schlaeffer, F., Bore, A. (2010). Urinary tract infections caused by multi-drug resistant Proteus mirabilis: Risk factors and clinical outcomes. Infection,38 (1), 41–46.10.1007/s15010-009-8460-519998053Search in Google Scholar

Hawser, S. P., Bouchillon, S. K., Hoban, D. J., Badal, R. E., Cantón, R., Baquero, F. (2010). Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum β-lactamases in community- and hospital-associated intra-abdominal infections in Europe: Results of the 2008 study for monitoring antimicrobial resistance trends (SMART). Antimicrob. Agents Chemother., 54 (7), 3043–3046.10.1128/AAC.00265-10289732320421398Search in Google Scholar

Hoffmann, H., Stürenberg, E., Husemann, J., Roggenkamp, A. (2006). Prevalence of extended-spectrum β-lactamases in isolates of the Enterobacter cloacae complex from German hospitals. Clin. Microbiol. Infect.,12 (4), 322–330.10.1111/j.1469-0691.2006.01360.x16524408Search in Google Scholar

Idowu, O., Onipede, A., Orimolade, A., Akinyoola, L., Babalola, G. (2011). Extended-spectrum beta-lactamase orthopedic wound infections in Nigeria. J. Glob. Infect. Dis., 3 (3), 211–215.10.4103/0974-777X.83524Search in Google Scholar

Jarlier V., Nicolas, M. H., Fournier, G., Philippon A. (1988). Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev. Infect. Dis., 10 (4), 867–878.10.1093/clinids/10.4.8673263690Search in Google Scholar

Kliebe, C., Nies, B., Meyer, J., Tolxdorff-Neutzling, R., Wiedemann, B. (1985). Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob. Agents Chemother.,28 (2), 302–307.10.1128/AAC.28.2.3021802363879659Search in Google Scholar

Knothe, H., Shah, P., Krcmery, V., Antal, M., Mitsuhashi, S. (1983). Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection, 11 (6), 315–317.10.1007/BF016413556321357Search in Google Scholar

Liakopoulos, A., Mevius, D., Ceccarelli, D. (2016). A review of SHV extended- spectrum β-lactamases: Neglected yet ubiquitous. Front. Microbiol., 7, 1374.10.3389/fmicb.2016.01374501113327656166Search in Google Scholar

Līduma, I. (2016). Staphyloccocus epidermidis virulence factors and epidemiological impact. (Staphylococcus epidermidis virulences faktori un epidemioloģiskā nozīme). Doctoral dissertation, University of Latvia, Rīga, Latvia.Search in Google Scholar

Luvsansharav, U., Hirai, I., Niki, M., Nakata, A., Yoshinaga, A., Yamamoto, A., Yamamoto, M., Toyoshima, H., Kawakami, F., Matsuura, N., Yamamoto, Y. (2013). Fecal carriage of CTX-M beta-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan. Infect. Drug Resist., 6, 67–70.10.2147/IDR.S43868Search in Google Scholar

Mulki, S. S., Ramamurthy, K., Bhat, S. (2017). Fecal carriage of extended- spectrum beta-lactamase-producing Enterobacteriaceae in intensive care unit patients. Indian J. Critical Care Med.,21 (8), 525–527.10.4103/ijccm.IJCCM_112_17558848828904483Search in Google Scholar

Ny, S., Löfmark, S., Börjesson, S., Englund, S., Ringman, M., Bergström, J., Nauclér, P., Giske, C. G., Byfors, S. (2017). Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: A Swedish nationwide study. J. Antimicrob. Chemother.,72 (2), 582–588.10.1093/jac/dkw41927798205Search in Google Scholar

Paberza, R., Selderiņa, S., Leja, S., Storoženko, J., Lužbinska, L., Žileviča, A. (2007). Prevalence of extended-spectrum β-lactamase producing Enterobacteriaceae strains in Latvia. Bioautomation,7, 99–103.Search in Google Scholar

Paterson, D. L., Bonomo, R. A. (2005). Extended-spectrum β-lactamases: A clinical update. Clin. Microbiol. Rev.,18 (4), 657–686.10.1128/CMR.18.4.657-686.2005126590816223952Search in Google Scholar

Petit, A., Gerbaud, G., Sirot, D., Courvalin, P., Sirot, J. (1990). Molecular epidemiology of TEM-3 (CTX-1) beta-lactamase. Antimicrob. Agents Chemother.,34, 219–224.10.1128/AAC.34.2.2191715602327769Search in Google Scholar

Rawat, D., Nair, D. (2010). Extended-spectrum β-lactamases in Gram negative bacteria. J. Glob. Infect. Dis., 2 (3), 263–274.10.4103/0974-777X.68531294668420927289Search in Google Scholar

Reuland, E., Naiemi, N., Kaiser, A., Heck, M., Kluytmans, J., Savelkoul, M., Elders, P., Vandenbroucke-Grauls, C. (2016). Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam. J. Antimicrob. Chemother., 71 (4), 1076–1082.10.1093/jac/dkv441479062026755493Search in Google Scholar

Rubio-Perez, I., Martin-Perez, E., Garcia, D., Lopez-Brea Calvo, M., Barrera, E. L. (2012). Extended-spectrum beta-lactamase-producing bacteria in a tertiary care hospital in Madrid: Epidemiology, risk factors and antimicrobial susceptibility patterns. Emerg. Health Threats J., 5, 10.10.3402/ehtj.v5i0.11589340074222822411Search in Google Scholar

Schoevaerdts, D., Verroken, A., Huang, T., Frennet, M., Berhin, C., Jamart, J., Bogaerts, P., Swine, C., Glupczynski, Y. (2012). Multidrug-resistant bacteria colonization amongst patients newly admitted to a geriatric unit: a prospective cohort study. J. Infect., 65 (2), 109–118.10.1016/j.jinf.2012.02.00422343066Search in Google Scholar

Shaikh, S., Fatima, J., Shakil, S., Rizvi, S., Kamal, M. (2015). Risk factors for acquisition of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae in North-Indian hospitals. Saudi J. Biol. Sci., 22 (1), 37–41.10.1016/j.sjbs.2014.05.006428160425561881Search in Google Scholar

Sharif, M. R., Soltani, B., Moravveji, A., Erami, M., Soltani, N. (2016). Prevalence and risk factors associated with extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae isolates in hospitalized patients in Kashan (Iran). Electron. Physician,8 (3), 2081–2087.10.19082/2081484447227123215Search in Google Scholar

Sibhghatulla, S., Jamale, F., Shazi S., Syed, M., Danish, R., Mohammad, A. K. (2015). Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J. Biol. Sci., 22 (1), 90–101.10.1016/j.sjbs.2014.08.002Search in Google Scholar

Skuja, V., Viksna, L., Kigitovica, D., Derovs, A., Pekarska, K., Caune, U., Piekuse, L., Kempa, I., Rudzite, D., Lejnieks, A., Krumina, A. (2015). Digestive system diseases as the most common disease group among patients with extended-spectrum beta-lactamase producing bacterial infection. In: Research Articles in Medicine & Pharmacy. Rīga Stradiņš University,Rīga, pp. 5–16.Search in Google Scholar

Spanu, T., Sanguinetti, M., Ciccaglione, D., D Inzeo, T., Romano, L., Leone, F., Fadda, G. (2003). Use of the VITEK 2 system for rapid identification of clinical isolates of staphylococci from bloodstream infections. J. Clin. Microbiol., 41 (9), 4259–4263.10.1128/JCM.41.9.4259-4263.200319379012958254Search in Google Scholar

Tängdén, T., Cars, O., Melhus, A., Löwdin, E. (2010). Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-Mtype extended-spectrum β-lactamases: a prospective study with Swedish volunteers. Antimicrob. Agents Chemother.,54 (9), 3564–3568.10.1128/AAC.00220-10293499320547788Search in Google Scholar

Tansarli, G., Poulikakos, P., Kapaskelis, A., Falagas, M. (2014). Proportion of extended-spectrum β-lactamase (ESBL)-producing isolates among Enterobacteriaceae in Africa: evaluation of the evidence—systematic review. J. Antimicrob. Chemother.,69, 1177–1184.10.1093/jac/dkt50024398340Search in Google Scholar

Tham, J., Walder, M., Melander, E., Odenholt, I. (2012). Duration of colonization with extended-spectrum beta-lactamase producing Escherichia coli in patients with travellers’ diarrhoea. Scand. J. Infect. Dis.,44, 573–577.10.3109/00365548.2011.65358222292796Search in Google Scholar

Willemsen, I., Oome, S., Verhulst, C., Pettersson, A., Verduin, K., Kluytmans, J. (2015). Trends in extended spectrum beta-lactamase (ESBL) producing Enterobacteriaceae and ESBL genes in a Dutch teaching hospital, measured in 5 yearly point prevalence surveys (2010–2014). PLoS ONE, 10 (11), e0141765.10.1371/journal.pone.0141765463133026528549Search in Google Scholar

Woerther, P. L., Burdet, C., Chachaty, E., Andremont, A. Trends in human fecal carriage of extended-spectrum β-lactamases in the community: Toward the globalization of CTX-M. (2013). Clin. Microbiol. Rev.,26 (4), 744–758.10.1128/CMR.00023-13381123224092853Search in Google Scholar

Yasmin, T., Yusuf, A., Sayam, M., Haque, R., Mowla, G. (2015). Status of ESBL producing bacteria isolated from skin wound at a tertiary care hospital in Bangladesh. Advances in Infectious Diseases,5, 174–179.10.4236/aid.2015.54022Search in Google Scholar

Zahar, J., Poirel, L., Dupont, C., Fortineau, N., Nassif, X., Nordmann, P. (2015). About the usefulness of contact precautions for carriers of extended- spectrum beta-lactamase-producing Escherichia coli. BMC Infect. Dis.,15, 512.10.1186/s12879-015-1244-x464267926563141Search in Google Scholar